ASCENSION SACRED HEART PENSACOLA
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.2M
- Transactions
- 539
- Companies
- 40
- Average per transaction
- $5,943
Who reported the payments
| Visby Medical, Inc. | $607,403 |
| Genentech, Inc. | $579,805 |
| Regeneron | $370,988 |
| Endotronix, Inc. | $252,105 |
| E.r. Squibb & Sons, L.L.C. | $234,788 |
| Amgen | $189,569 |
| Cleerly, Inc. | $169,748 |
| Bristol Myers Squibb | $157,543 |
| Janssen Research & Development, LLC | $100,335 |
| Jazz Pharmaceuticals Inc. | $88,250 |
| Angiodynamics, Inc. | $49,333 |
| Medtronic | $46,904 |
| Inari Medical, Inc. | $45,408 |
| Medical Device Business Services, Inc. | $40,080 |
| Procyrion, Inc. | $30,950 |
| Cepheid | $26,000 |
| Pfizer | $24,875 |
| Incyte Corporation | $22,858 |
| Merck | $18,325 |
| Alnylam Pharmaceuticals Inc. | $17,250 |
| TG Therapeutics, Inc. | $16,600 |
| Pharmacyclics LLC, An Abbvie Company | $15,700 |
| Beone Medicines USA, Inc. | $15,330 |
| Meridian Bioscience Inc. | $14,494 |
| Portola Pharmaceuticals, LLC | $14,000 |
| KARL Storz Endoscopy-america | $9,620 |
| Acell, Inc. | $6,481 |
| Johnson & Johnson | $5,053 |
| Biotronik Inc. | $4,059 |
| Smith+Nephew | $3,895 |
| Stryker | $3,663 |
| Genentech USA, Inc. | $3,000 |
| Roche Molecular Systems, Inc. | $2,000 |
| Novartis | $2,000 |
| Baxter Healthcare | $1,808 |
| Edwards Lifesciences | $1,607 |
| Regeneron Healthcare Solutions, Inc. | $1,500 |
| Sanofi | $1,500 |
| AstraZeneca | $1,500 |
| Taiho Oncology, Inc. | $1,500 |